SLI
VRTX icon

Sumitomo Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Sumitomo Life Insurance’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Sell
6,558
-1,197
-15% -$530K 0.05% 95
2026
Q1 		$3.46M Sell
7,755
-371
-5% -$173K 0.08% 84
2025
Q4 		$3.68M Buy
8,126
+1,033
+15% +$445K 0.1% 88
2025
Q3 		$2.78M Sell
7,093
-143
-2% -$59.8K 0.09% 100
2025
Q2 		$3.22M Sell
7,236
-301
-4% -$139K 0.22% 79
2025
Q1 		$3.65M Sell
7,537
-76
-1% -$35.4K 0.13% 73
2024
Q4 		$3.07M Sell
7,613
-115
-1% -$53.3K 0.06% 87
2024
Q3 		$3.59M Buy
7,728
+128
+2% +$61.5K 0.07% 70
2024
Q2 		$3.56M Sell
7,600
-98
-1% -$42.5K 0.08% 68
2024
Q1 		$3.22M Sell
7,698
-224
-3% -$94.7K 0.08% 74
2023
Q4 		$3.22M Buy
7,922
+17
+0.2% +$6.28K 0.1% 66
2023
Q3 		$2.75M Buy
7,905
+118
+2% +$41.3K 0.08% 64
2023
Q2 		$2.74M Buy
7,787
+2,814
+57% +$948K 0.12% 66
2023
Q1 		$1.57M Buy
+4,973
New +$1.49M 0.13% 126

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sumitomo Life Insurance's VRTX Position: Q2 2026 in Review

Sumitomo Life Insurance reduced its Vertex Pharmaceuticals (VRTX) stake by 15% in Q2 2026, selling an estimated $530K and leaving 6,558 shares worth $3.26M. The position accounts for 0.05% of the portfolio, ranked #95.

Sumitomo Life Insurance first reported a position in VRTX in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.68M in Q4 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Sumitomo Life Insurance held 6,558 shares of Vertex Pharmaceuticals worth $3.26M as of Q2 2026.
  • Sumitomo Life Insurance sold 1,197 Vertex Pharmaceuticals shares in Q2 2026, an estimated $530K.
  • Vertex Pharmaceuticals made up 0.05% of Sumitomo Life Insurance's portfolio in Q2 2026, its #95 holding.
  • Sumitomo Life Insurance first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
  • Sumitomo Life Insurance's Vertex Pharmaceuticals position peaked at $3.68M in Q4 2025.
  • 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sumitomo Life Insurance's 13F filing for Q2 2026, filed 12 Aug 2026.